By Dominic Chopping

 

Danish biotechnology company Bavarian Nordic A/S said Friday that the funding agreement with the Danish Ministry of Health to further advance the company's Covid-19 vaccine candidate, has now been approved by the Finance Committee of the Danish Parliament, thereby finally executing the agreement.

 

Write to Dominic Chopping at dominic.chopping@wsj.com

 

(END) Dow Jones Newswires

September 24, 2021 05:14 ET (09:14 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.